
Sign up to save your podcasts
Or


Dr. Bob Harrington, an interventional cardiologist and Chairman of the Department of Medicine at Stanford University, speaks with Venrock's Dr. Bob Kocher about his passion for coagulation and thrombosis (seriously, he loves it) and his involvement with Gusto, a clinical trial that changed the way doctors treat heart attack patients. Bob also talks about working with an executive coach to develop new skills, when he found himself managing teams at Duke Clinical Research Institute.
By Venrock, a venture capital firm4.8
6262 ratings
Dr. Bob Harrington, an interventional cardiologist and Chairman of the Department of Medicine at Stanford University, speaks with Venrock's Dr. Bob Kocher about his passion for coagulation and thrombosis (seriously, he loves it) and his involvement with Gusto, a clinical trial that changed the way doctors treat heart attack patients. Bob also talks about working with an executive coach to develop new skills, when he found himself managing teams at Duke Clinical Research Institute.

1,285 Listeners

2,689 Listeners

2,456 Listeners

1,094 Listeners

337 Listeners

320 Listeners

390 Listeners

5,568 Listeners

9,955 Listeners

33 Listeners

516 Listeners

20 Listeners

282 Listeners

472 Listeners

1,432 Listeners